654076

GlaxoSmithKline LLC — FEI 1035048

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 19, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Durham, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)